Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Claire E. Badenhorst, Kazushige Goto, Wendy J. O’Brien & Stacy Sims. (2021) Iron status in athletic females, a shift in perspective on an old paradigm. Journal of Sports Sciences 39:14, pages 1565-1575.
Read now
Read now
Ann-Kathrin Frenz, Christiane Ahlers, Vita Beckert, Christoph Gerlinger & Tim Friede. (2021) Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems. The European Journal of Contraception & Reproductive Health Care 26:1, pages 48-57.
Read now
Read now
Vita Beckert, Christiane Ahlers, Ann-Kathrin Frenz, Christoph Gerlinger, Ralf Bannemerschult & Eeva Lukkari-Lax. (2019) Bleeding patterns with the 19.5 mg LNG-IUS, with special focus on the first year of use: implications for counselling. The European Journal of Contraception & Reproductive Health Care 24:4, pages 251-259.
Read now
Read now
Thomas Strowitzki, Thomas Faustmann, Christoph Gerlinger, Ulrike Schumacher, Christiane Ahlers & Christian Seitz. (2015) Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. International Journal of Women's Health 7, pages 393-401.
Read now
Read now
Articles from other publishers (13)
Andreas D. Ebert, Liying Dong, Martin Merz, Bodo Kirsch, Maja Francuski, Bettina Böttcher, Horace Roman, Pia Suvitie, Olga Hlavackova, Kerstin Gude & Christian Seitz. (2017) Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents. Journal of Pediatric and Adolescent Gynecology 30:5, pages 560-567.
Crossref
Crossref
Elizabeth M. Miller. (2016) The reproductive ecology of iron in women. American Journal of Physical Anthropology 159, pages 172-195.
Crossref
Crossref
Rong Zhang, Ting-Yan Shi, Yuan Ren, Huan Lu, Zhen-Hong Wei, Wen-Jing Hou, Ming Zhang & Congjian Xu. (2013) Risk factors for human papillomavirus infection in Shanghai suburbs: A population-based study with 10,000 women. Journal of Clinical Virology 58:1, pages 144-148.
Crossref
Crossref
Ulrike Schumacher, Jens Schumacher, Uwe Mellinger, Christoph Gerlinger, Andreas Wienke & Jan Endrikat. (2012) Estimation of menstrual blood loss volume based on menstrual diary and laboratory data. BMC Women's Health 12:1.
Crossref
Crossref
Joachim Marr, Christoph Gerlinger & Michael Kunz. (2012) A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30μg/drospirenone 3mg administered in a 21/7 regimen versus ethinylestradiol 20μg/drospirenone 3mg administered in a 24/4 regimen. European Journal of Obstetrics & Gynecology and Reproductive Biology 162:1, pages 91-95.
Crossref
Crossref
Felice Petraglia, Daniela Hornung, Christian Seitz, Thomas Faustmann, Christoph Gerlinger, Stefano Luisi, Lucia Lazzeri & Thomas Strowitzki. (2011) Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Archives of Gynecology and Obstetrics 285:1, pages 167-173.
Crossref
Crossref
Jos? Alfredo Sierra-Ram?rez, Roger Lara-Ricalde, Miguel Lujan, Norma Vel?zquez-Ram?rez, Marycarmen God?nez-Victoria, Ivonne Araceli Hern?dez-Mungu?a, Agustin Padilla & Josu? Garza-Flores. (2011) Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg). Contraception 84:6, pages 565-570.
Crossref
Crossref
Inka Wiegratz, Skadi Stahlberg, Torsten Manthey, Nicole S?nger, Katrin Mittmann, Evelyn Lange, Uwe Mellinger, Ernesta Palombo-Kinne & Herbert Kuhl. (2011) Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy. Contraception 84:2, pages 133-143.
Crossref
Crossref
Thomas Strowitzki, Thomas Faustmann, Christoph Gerlinger & Christian Seitz. (2010) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. European Journal of Obstetrics & Gynecology and Reproductive Biology 151:2, pages 193-198.
Crossref
Crossref
Sue Kelly, Emyr Davies, Simon Fearns, Carol McKinnon, Rick Carter, Christoph Gerlinger & Andrew Smithers. (2010) Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women. Clinical Drug Investigation 30:5, pages 325-336.
Crossref
Crossref
Richard F. Lynen. (2010) Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill: A Randomized Controlled Trial. Obstetrics & Gynecology 115:4, pages 867.
Crossref
Crossref
T. Strowitzki, J. Marr, C. Gerlinger, T. Faustmann & C. Seitz. (2010) Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Human Reproduction 25:3, pages 633-641.
Crossref
Crossref
Patricia J. Sulak, Virginia Smith, Andrea Coffee, Iris Witt, Alicia L. Kuehl & Thomas J. Kuehl. (2008) Frequency and Management of Breakthrough Bleeding With Continuous Use of the Transvaginal Contraceptive Ring. Obstetrics & Gynecology 112:3, pages 563-571.
Crossref
Crossref